🔖
Bu Makaleye Atıf Yap
DAL, H. C. (2022). Septik Şokta Levosimendan Kullanımı. Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi, Cilt: 8 - Sayı: 1, 39–40. https://ajindex.com/articles/486551
Dergiler / Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi / 2017 / Cilt: 8 - Sayı: 1
Septik Şokta Levosimendan Kullanımı
- Sayfa
- 39–40
- Yayın Tarihi
- 2022-10-11
- DOI
- —
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗Kaynakça (1)
- Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 775-87. [CrossRef] 2. Schmittinger CA, Torgersen C, Luckner G, et al. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 2012; 38: 950-8. [CrossRef] 3. Ukkonen H, Saraste M, Akkila J, et al. Myocardial efficiency during calcium sensitization with levosimendan: a noninvasive study with positron emission tomography and echocardiography in healthy volunteers. Clin Pharmacol Ther 1997; 61: 596-607. [CrossRef] 4. Zangrillo A, Putzu A, Monaco F, et al. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials. J Crit Care 2015; 30: 908-13. [CrossRef] 5. Gordon AC, Perkins GD, Singer M, et al. Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis. N Engl J Med 2016; 375: 1638-48. [CrossRef] 6. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 304-77.[CrossRef]